Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032453959> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W3032453959 endingPage "564" @default.
- W3032453959 startingPage "560" @default.
- W3032453959 abstract "派立明是一种最新型的局部碳酸酐酶抑制剂.此药可选择性、高亲和力及明显地抑制碳酸酐酶同功酶Ⅱ的活性,有效地降低眼压.本品滴眼后可快速进入眼组织,在虹膜、睫状体、脉络膜、视网膜、晶状体和血液中有较长的半衰期(数天).虽然用派立明滴眼后,可在全血中测出药物浓度,提示该药可全身吸收,但主药和其代谢产物的血浆浓度非常低,在稳定状态下药物与红细胞内碳酸酐酶的结合达不到完全饱和.因此,不会出现全身酸中毒或其他与口服碳酸酐酶抑制剂有关的副作用.对兔眼滴用派立明还可增加视乳头血流量,而对全身酸碱平衡的影响极小.如这一作用在人眼被证实,将对有视神经病变的青光眼患者十分有益.1%派立明每日滴眼2次的降眼压效果最好,且患者的耐受性较多佐胺好,这可提高患者长期用药的依从性.滴眼后最常见的副作用是视物模糊(6%)及口苦、口酸等味觉异常(6%).总之,派立明的降眼压作用强,副作用小,滴眼舒适,患者耐受性好,是一种非常有价值的抗青光眼新药." @default.
- W3032453959 created "2020-06-05" @default.
- W3032453959 creator A5034672996 @default.
- W3032453959 creator A5053251744 @default.
- W3032453959 creator A5072943477 @default.
- W3032453959 date "2002-11-10" @default.
- W3032453959 modified "2023-09-25" @default.
- W3032453959 title "Preclinical and clinical studies on brinzolamide,the newest topical carbonic anhydrase inhibitor" @default.
- W3032453959 doi "https://doi.org/10.3760/cma.j.issn.2095-0160.2002.06.025" @default.
- W3032453959 hasPublicationYear "2002" @default.
- W3032453959 type Work @default.
- W3032453959 sameAs 3032453959 @default.
- W3032453959 citedByCount "0" @default.
- W3032453959 crossrefType "journal-article" @default.
- W3032453959 hasAuthorship W3032453959A5034672996 @default.
- W3032453959 hasAuthorship W3032453959A5053251744 @default.
- W3032453959 hasAuthorship W3032453959A5072943477 @default.
- W3032453959 hasConcept C126322002 @default.
- W3032453959 hasConcept C181199279 @default.
- W3032453959 hasConcept C185592680 @default.
- W3032453959 hasConcept C2775914622 @default.
- W3032453959 hasConcept C2777405951 @default.
- W3032453959 hasConcept C2778076468 @default.
- W3032453959 hasConcept C55493867 @default.
- W3032453959 hasConcept C71924100 @default.
- W3032453959 hasConcept C98274493 @default.
- W3032453959 hasConceptScore W3032453959C126322002 @default.
- W3032453959 hasConceptScore W3032453959C181199279 @default.
- W3032453959 hasConceptScore W3032453959C185592680 @default.
- W3032453959 hasConceptScore W3032453959C2775914622 @default.
- W3032453959 hasConceptScore W3032453959C2777405951 @default.
- W3032453959 hasConceptScore W3032453959C2778076468 @default.
- W3032453959 hasConceptScore W3032453959C55493867 @default.
- W3032453959 hasConceptScore W3032453959C71924100 @default.
- W3032453959 hasConceptScore W3032453959C98274493 @default.
- W3032453959 hasIssue "6" @default.
- W3032453959 hasLocation W30324539591 @default.
- W3032453959 hasOpenAccess W3032453959 @default.
- W3032453959 hasPrimaryLocation W30324539591 @default.
- W3032453959 hasRelatedWork W1585666617 @default.
- W3032453959 hasRelatedWork W1970977423 @default.
- W3032453959 hasRelatedWork W1980848111 @default.
- W3032453959 hasRelatedWork W1982970232 @default.
- W3032453959 hasRelatedWork W2014446622 @default.
- W3032453959 hasRelatedWork W2020082532 @default.
- W3032453959 hasRelatedWork W2054314888 @default.
- W3032453959 hasRelatedWork W2077519491 @default.
- W3032453959 hasRelatedWork W2106404230 @default.
- W3032453959 hasRelatedWork W2289414610 @default.
- W3032453959 hasRelatedWork W2383313381 @default.
- W3032453959 hasRelatedWork W2403960212 @default.
- W3032453959 hasRelatedWork W2409904944 @default.
- W3032453959 hasRelatedWork W2417287431 @default.
- W3032453959 hasRelatedWork W3011727570 @default.
- W3032453959 hasRelatedWork W3115892211 @default.
- W3032453959 hasVolume "20" @default.
- W3032453959 isParatext "false" @default.
- W3032453959 isRetracted "false" @default.
- W3032453959 magId "3032453959" @default.
- W3032453959 workType "article" @default.